SAM
Sompo Asset Management’s Biogen BIIB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-1,200
| Closed | -$233K | – | 197 |
|
2024
Q3 | $233K | Sell |
1,200
-260
| -18% | -$50.4K | 0.04% | 183 |
|
2024
Q2 | $338K | Buy |
1,460
+390
| +36% | +$90.4K | 0.06% | 167 |
|
2024
Q1 | $231K | Buy |
+1,070
| New | +$231K | 0.04% | 190 |
|
2023
Q4 | – | Sell |
-1,100
| Closed | -$283K | – | 193 |
|
2023
Q3 | $283K | Buy |
+1,100
| New | +$283K | 0.06% | 168 |
|
2023
Q2 | – | Sell |
-950
| Closed | -$264K | – | 172 |
|
2023
Q1 | $264K | Hold |
950
| – | – | 0.06% | 156 |
|
2022
Q4 | $263K | Buy |
+950
| New | +$263K | 0.06% | 166 |
|
2021
Q4 | – | Sell |
-2,870
| Closed | -$812K | – | 155 |
|
2021
Q3 | $812K | Sell |
2,870
-2,430
| -46% | -$688K | 0.19% | 111 |
|
2021
Q2 | $1.84M | Sell |
5,300
-550
| -9% | -$190K | 0.38% | 79 |
|
2021
Q1 | $1.64M | Sell |
5,850
-2,800
| -32% | -$784K | 0.37% | 84 |
|
2020
Q4 | $2.12M | Buy |
8,650
+3,450
| +66% | +$845K | 0.46% | 69 |
|
2020
Q3 | $1.48M | Sell |
5,200
-560
| -10% | -$159K | 0.36% | 82 |
|
2020
Q2 | $1.54M | Buy |
5,760
+4,220
| +274% | +$1.13M | 0.39% | 77 |
|
2020
Q1 | $487K | Buy |
+1,540
| New | +$487K | 0.13% | 107 |
|
2018
Q3 | – | Sell |
-9,800
| Closed | -$2.84M | – | 95 |
|
2018
Q2 | $2.84M | Sell |
9,800
-2,550
| -21% | -$740K | 0.64% | 55 |
|
2018
Q1 | $3.38M | Sell |
12,350
-110
| -0.9% | -$30.1K | 0.55% | 59 |
|
2017
Q4 | $3.97M | Sell |
12,460
-1,990
| -14% | -$634K | 0.58% | 60 |
|
2017
Q3 | $4.53M | Sell |
14,450
-1,500
| -9% | -$470K | 0.69% | 54 |
|
2017
Q2 | $4.33M | Sell |
15,950
-2,910
| -15% | -$790K | 0.65% | 60 |
|
2017
Q1 | $5.16M | Sell |
18,860
-390
| -2% | -$107K | 0.64% | 64 |
|
2016
Q4 | $5.46M | Buy |
+19,250
| New | +$5.46M | 0.71% | 63 |
|